11 March 2026 - Amid mounting opposition from the pharmaceutical industry over the government's proposed “drug pricing system improvement plan,” the Ministry of Health and Welfare reaffirmed that the core issue of generic drug price reductions is a “principle with no exceptions.”
However, the ministry took a cautious stance on potentially postponing the implementation of the revised plan, leaving the possibility open.